Northeast Investment Management Sells 582 Shares of The Clorox Company (NYSE:CLX)

Northeast Investment Management reduced its stake in shares of The Clorox Company (NYSE:CLX) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,224 shares of the company’s stock after selling 582 shares during the quarter. Northeast Investment Management’s holdings in Clorox were worth $8,807,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Czech National Bank grew its stake in shares of Clorox by 6.6% in the 3rd quarter. Czech National Bank now owns 25,232 shares of the company’s stock valued at $4,111,000 after purchasing an additional 1,567 shares during the period. Wealth Group Ltd. acquired a new stake in shares of Clorox in the 3rd quarter valued at $231,000. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Clorox by 256.4% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,112 shares of the company’s stock valued at $181,000 after purchasing an additional 800 shares during the last quarter. Valeo Financial Advisors LLC increased its holdings in shares of Clorox by 8.0% during the third quarter. Valeo Financial Advisors LLC now owns 3,710 shares of the company’s stock worth $604,000 after buying an additional 276 shares in the last quarter. Finally, Gateway Investment Advisers LLC grew its position in Clorox by 3.0% during the 3rd quarter. Gateway Investment Advisers LLC now owns 8,589 shares of the company’s stock worth $1,399,000 after acquiring an additional 252 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

CLX opened at $148.51 on Friday. The firm’s fifty day moving average price is $161.06 and its two-hundred day moving average price is $158.70. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The company has a market capitalization of $18.38 billion, a price-to-earnings ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business earned $2.16 EPS. As a group, analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s payout ratio is presently 133.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CLX shares. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Barclays upped their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and an average target price of $158.21.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.